Stock screenerAll disclosures →
EDGAR →
PRLD
Conviction 69HealthcareScan · Mon, Aug 10, 2026PRLD$4.83-1.43%
ResistanceSupportVol 14Insider buyVol MA14 447.63K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price4.83
Change-1.43%
Gap+1.53%
Rel volume4.10×
Avg volume390.99K
Avg $ vol1.77M
SMA 204.39
SMA 504.38
SMA 2003.22
Price vs 50+10.28%
Price vs 200+50.03%
MA stackbullish
50/200 cross—
Supertrendup · 3.89
RSI (14)57
MACD hist0.06
MACD crossbull · 8d
Stoch %K / %D77 / 75
ADX (14)19
+DI / −DI26 / 15
RSI divergence—
MACD divergence—
ATR %+7.31%
ADR %7.01%
52w high5.52
52w low0.8270
From 52w high-12.50%
Above 52w low+484.04%
New 52w highNo
SqueezeOff
Bollinger width32.42%
%B0.81
Donchian pos76.81%
Donchian high5.15
Donchian low3.77
AVWAP (52w high)4.67
vs AVWAP high+3.40%
AVWAP (52w low)2.83
vs AVWAP low+70.41%
OBV trendFlat
Chaikin MF (20)-0.12
Today vs 20d4.10×
Avg vol (14d)447.63K
Avg vol (20d)390.99K
Avg $ vol (20d)1.77M
Market cap—
RS 3m (vs SPY)-10.55%
RS 6m (vs SPY)+128.46%
RS line new highNo
Trend template7/8
Technical rank90.1
1 week+10.02%
1 month+0.52%
3 months-0.62%
6 months+122.58%
1 year+463.59%
YTD+76.92%
P/E-3.92
P/B6.48
P/S32.11
P/FCF-6.92
EPS-1.29
Div yield—
ROE-165.33%
ROA-83.16%
Debt/Eq—
Current2.03
EV/EBITDA-3.58
Gross margin—
Net margin-819.59%
Rev growth73.43%
EPS growth21.76%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value368.11M
Revenue4.58M
Net income-10.38M
Gross profit—
Free cash flow-56.37M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out79.65M
Employees79
ListedFri, Sep 25, 2020
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeB
Conviction69 / 100
Pattern quality—
Tech rank90.1 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance5.51
Support3.77
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in PRLD
No recent disclosed trades by Congress in PRLD. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in PRLD · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Babler Martin Director · Director Stock Option (Right to Buy) · 2026-06-09 | Grant | 38K | $0 | 2026-06-09 | 2026-06-10 |
Baker Bros. Advisors (GP) LLC Director · Non-Qualified Stock Option (right to buy) · 2026-06-09 | Grant | 38K | $0 | 2026-06-09 | 2026-06-10 |
BAKER BROS. ADVISORS LP Director · Non-Qualified Stock Option (right to buy) · 2026-06-09 | Grant | 38K | $0 | 2026-06-09 | 2026-06-10 |
Sandor Victor Director · Director Stock Option (Right to Buy) · 2026-06-09 | Grant | 38K | $0 | 2026-06-09 | 2026-06-10 |
BAKER JULIAN Director · Non-Qualified Stock Option (right to buy) · 2026-06-09 | Grant | 38K | $0 | 2026-06-09 | 2026-06-10 |
Baker Brothers Life Sciences LP Director · Non-Qualified Stock Option (right to buy) · 2026-06-09 | Grant | 38K | $0 | 2026-06-09 | 2026-06-10 |
BAKER FELIX Director · Non-Qualified Stock Option (right to buy) · 2026-06-09 | Grant | 38K | $0 | 2026-06-09 | 2026-06-10 |
Dorton Katina Director · Director Stock Option (Right to Buy) · 2026-06-09 | Grant | 38K | $0 | 2026-06-09 | 2026-06-10 |
Bonita David P Director · Director Stock Option (Right to Buy) · 2026-06-09 | Grant | 38K | $0 | 2026-06-09 | 2026-06-10 |
FRIEDMAN PAUL A Director · Director Stock Option (Right to Buy) · 2026-06-09 | Grant | 38K | $0 | 2026-06-09 | 2026-06-10 |
SEC filings
EDGAR filings in PRLD · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.